Planet 13 Holdings (PLNH) Asset Writedowns and Impairment (2021 - 2025)
Planet 13 Holdings (PLNH) posted quarterly Asset Writedowns and Impairment of $11.7 million for Q4 2025, up 1284.67% year-over-year from $846449.0 in Q4 2024, and up 100.01% quarter-over-quarter from $5.9 million in Q3 2025.
Planet 13 Holdings (PLNH) Asset Writedowns and Impairment (2021 - 2025) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Asset Writedowns and Impairment for 5 consecutive years, with $11.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Asset Writedowns and Impairment rose 1284.67% year-over-year to $11.7 million; the TTM figure through Dec 2025 stood at $20.1 million (down 59.33% YoY), while the FY2025 annual figure was $17.6 million, up 442.69% from the prior year.
- Asset Writedowns and Impairment advanced to $11.7 million in Q4 2025 per PLNH's latest filing, from $5.9 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $46.8 million in Q4 2023 and bottomed at -$3.3 million in Q4 2021.
- Historically, Asset Writedowns and Impairment has averaged $5.7 million across 5 years, with a median of $950585.0 in 2022.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment plunged 162.1% — and 2025, when it soared 1284.67%.
- Planet 13 Holdings' Asset Writedowns and Impairment stood at -$3.3 million in 2021, then soared by 308.46% to $6.9 million in 2022, then surged by 574.27% to $46.8 million in 2023, then slumped by 98.19% to $846449.0 in 2024, then jumped by 1284.67% to $11.7 million in 2025.
- Business Quant data shows PLNH's Asset Writedowns and Impairment at $11.7 million in Q4 2025, $5.9 million in Q3 2025, and $846449.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Planet 13 Holdings | 52.64 Mn | 36.16 Mn | 12.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.72 Mn |
| Dec 31, 2025 | 11.72 Mn |
| Sep 30, 2025 | 5.86 Mn |
| Sep 30, 2025 | 5.86 Mn |
| Dec 31, 2024 | 846,449.00 |
| Dec 31, 2024 | 846,449.00 |
| Sep 30, 2024 | 1.63 Mn |
| Sep 30, 2024 | 1.63 Mn |
| Dec 31, 2023 | 46.85 Mn |
| Dec 31, 2023 | 46.85 Mn |
| Dec 31, 2022 | 6.95 Mn |
| Dec 31, 2022 | 6.95 Mn |
| Sep 30, 2022 | -1.80 Mn |
| Sep 30, 2022 | -1.80 Mn |
| Jun 30, 2022 | 849,008.00 |
| Jun 30, 2022 | 849,008.00 |
| Mar 31, 2022 | 950,585.00 |
| Mar 31, 2022 | 950,585.00 |
| Dec 31, 2021 | -3.33 Mn |
| Dec 31, 2021 | -3.33 Mn |